Download PDF
Thromb Haemost 1988; 59(02): 304-309
DOI: 10.1055/s-0038-1642776
Original Articles
Schattauer GmbH Stuttgart

Comparison of the Platelet Aggregation Induced by Three Thrombin-Like Enzymes of Snake Venoms and Thrombin

Che-Ming Teng
The Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan
,
Feng-Nien Ko
The Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan
› Author Affiliations
Further Information

Publication History

Received 11 June 1987

Accepted after revision 24 December 1987

Publication Date:
21 May 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Platelet aggregation induced by three thrombin-like enzymes of snake venoms was compared with that by thrombin. Acutin was isolated from Agkistrodon acutus venom and thrombocytin and batroxobin were from Bothrops atrox venom. The fibrinogenclotting activities were 700,170 and 7 U/mg for batroxobin, acutin and thrombocytin, respectively. They induced aggregation and ATP release of washed rabbit platelets. The aggregating activity of thrombin was 102, 104 and 105 times more potent than those of thrombocytin, acutin and batroxobin, respectively. Plateletactivating potency of the thrombin-like enzymes was correlated with their effectiveness on the retractility and elasticity of the clots. Platelet aggregation induced by thrombin or thrombocytin could be inhibited by heparin with antithrombin III while that by acutin or batroxobin could not. Indomethacin showed weak inhibition on the aggregation while the ADP-scavenging system, creatine phosphate/creatine phosphokinase, inhibited the aggregation induced by the three thrombin-like enzymes but not that by thrombin. Platelet aggregation induced by the thrombin-like enzymes could not be inhibited by PAF antagonists-BN 52021, kadsurenone or L-652,731. In the presence of EGTA, only thrombin could induce ATP release from platelets. Thrombin-like enzymes and low concentration of thrombin did not form thromboxane B2. Nitroprusside and prostaglandin E1 completely inhibited the aggregation, mepacrine and imipramine showed marked inhibition while verapamil had only weak inhibition. It is concluded that the aggregation induced by the thrombin-like enzymes is different from that of thrombin and mainly due to ADP released from platelets.

Keywords

Platelet aggregation - Thrombin-like enzyme - Snake venom - ADP pathway
 

  • References

  • 1 Copley AL, Banerjee S, Devi A. Studies of snake venoms on blood coagulation. I. The thromboserpentin (thrombin-like) enzymes in the venoms. Thromb Res 1973; 2: 487-508
    CrossrefPubMedGoogle Scholar
  • 2 Seegers WH, Ouyang C. Snake venoms and blood coagulation. In: Handbook of Experimental Pharmacology 1979; 52: 684-740
    PubMedGoogle Scholar
  • 3 Markland FS, Demus PS. Purification and properties of a thrombin-like enzymes from the venom of Crotalus adamanteus (Eastern diamondback rattlesnake). J Biol Chem 1971; 246: 6460-6473
    PubMedGoogle Scholar
  • 4 Holleman WH, Coen LJ. Characterization of peptides released from human fibrinogen by Arvin. Biochim Biophys Acta 1970; 200: 587-589
    CrossrefPubMedGoogle Scholar
  • 5 Stocker K, Egberg N. Reptilase as a defibrinogenating agent. Thrombos Diathes Haemorrh Suppl (Suppl. 01) 1973; 54: 361-369
    PubMedGoogle Scholar
  • 6 Ouyang C, Hong JS, Teng CM. Purification and properties of the thrombin-like principle of Agkistrodon acutus venom and its compari-son with bovine thrombin. Thrombos Diathes Haemorrh 1971; 26: 224-234
    PubMedGoogle Scholar
  • 7 Ouyang C, Teng CM. The effect of the purified thrombin-like and anticoagulant principles of Agkistrodon acutus venom on bloodcoagulation in vivo. Toxicon 1973; 14: 49-54
    PubMedGoogle Scholar
  • 8 Pizzo SV, Schwartz ML, Hill RL, McKee PA. Mechanism of ancrodanticoagulation A direct proteolytic effect on fibrin. J Clin Invest 1972; 51: 2841-2850
    CrossrefPubMedGoogle Scholar
  • 9 Brown III CH, Bell WR, Shreiner DP, Jackson DP. Effects of Arvinon blood platelets in vitro and in vivo studies. J Lab Clin Med 1972; 79: 758-769
    PubMedGoogle Scholar
  • 10 de Gaetano G, Bottecchia D, Vermylen J. Retraction of reptilase-clotsin the presence of agents inducing or inhibiting the platelet adhesion-aggregation reaction. Thromb Res 1973; 32: 232-238
    PubMedGoogle Scholar
  • 11 Tangen O, Wik OK, Berman HJ. The effect of thrombin reptilaseand a fibrinopeptide B-releasing enzyme from the venom of southerncopperhead snake on rabbit platelets. Microvasc Res 1973; 6: 342-346
    CrossrefPubMedGoogle Scholar
  • 12 Ouyang C, Teng CM. In vivo effects of the purified thrombin-like andanticoagulant principles of Agkistrodon acutus (Hundred-pace snake)venom. Toxicon 1978; 16: 583-593
    CrossrefPubMedGoogle Scholar
  • 13 Niewiarowski S, Kirby EP, Brudzynski TM, Stocker K. Thrombocytin a serine protease from Bothrops atrox venom II Interaction withplatelets and plasma clotting factors. Biochemistry 1979; 18: 3570-3577
    CrossrefPubMedGoogle Scholar
  • 14 Stocker K, Barlow GH. The coagulant enzyme from Bothrops atrox venom (batroxobin). Methods Enzymol 1976; 45: 214-222
    PubMedGoogle Scholar
  • 15 Seegers WH, Smith HP. Factors which influence the activity ofpurified thrombin. Am J Physiol 1942; 137: 348-354
    CrossrefPubMedGoogle Scholar
  • 16 O’Brien JR. Platelet aggregation II Some results from a new methodof study. J Clin Path 1962; 15: 452-455
    CrossrefPubMedGoogle Scholar
  • 17 Teng CM, Ko FN. Characterization of the platelet aggregationinducers from Bothrops atrox snake venom. Prepared for publication.
    PubMedGoogle Scholar
  • 18 Ouyang C, Chen YC, Teng CM. The clotting activity of thethrombin-like enzyme of Agkistrodon acutus (Hundred pace snake)venom. Toxicon 1979; 17: 313-316
    CrossrefPubMedGoogle Scholar
  • 19 Workman Jr EF, White GC II, Landblad RL. Structure-functionrelationships in the interaction of alphathrombin with blood platelets. J Biol Chem 1977; 252: 7118-7123
    PubMedGoogle Scholar
  • 20 White GC II, Lundblad RL, Griffith MJ. Structure-functionrelations in platelet-thrombin reaction Inhibition of platelet-thrombininteractions by lysine modification. J Biol Chem 1981; 256: 1763-1766
    PubMedGoogle Scholar
  • 21 Teng CM, Liao KK, Wang JP, Lin HS, Ouyang C. Ultrastructuralchanges and release reaction of platelets induced by an aggregationinducer purified from Trimeresurus mucrosquamatus (FormosanHabu) snake venom. Biochim Biophys Acta 1985; 841: 8-14
    CrossrefPubMedGoogle Scholar
  • 22 Vargaftig BB. Platelet activation by non-coagulant snake venomcomponents. Toxicon 1982; 20: 279-287
    CrossrefPubMedGoogle Scholar
  • 23 Ouyang C, Huang TF. A potent platelet aggregation inducer from Trimeresurus gramineus snake venom. Biochim Biophys Acta 1983; 761: 126-134
    CrossrefPubMedGoogle Scholar
  • 24 Blasko G, Machovich R. Thrombin-like proteinases of snake venoms:clinical applications of thrombin and thrombin-like enzymes. In: TheThrombin 1984; Vol II: 89-104
    PubMedGoogle Scholar
  • 25 Stocker K, Fischer H, Meier J. Thrombin-like snake venom pro-teinases. Toxicon 1982; 20: 265-273
    CrossrefPubMedGoogle Scholar
  • 26 Nishizaka Y. The role of protein kinase C in cell surface signaltransduction and tumor promotion. Nature 1984; 308: 693-698
    CrossrefPubMedGoogle Scholar
  • 27 Milk DC B, Smith JB. The influence on platelet aggregation of drugsthat affect the accumulation of adenosine 3’5’–cyclic monophosphatein platelets. Biochem J 1971; 121: 185-196
    CrossrefPubMedGoogle Scholar
  • 28 Theomellion B, Ignarro LJ, Ohistein EH, Pontecorva EG, Hyman AL, Kadowitz PJ. Evidence for the inhibitory role of guanosine 3’5’monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilators. Blood 1981; 57: 946-955
    PubMedGoogle Scholar
  • 29 Berridge MJ, Irvine RF. Inositol triphosphate a novel secondmessenger in cellular signal tranduction. Nature 1984; 312: 315-321
    CrossrefPubMedGoogle Scholar
  • 30 Braquet P, Godfroid JJ. PAF-acether specific binding sites: 2 Design of specific antagonists. Trends Pharmacol 1986; 7: 397-403
    CrossrefPubMedGoogle Scholar